These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15709291)

  • 1. Birth control: more & safer choices.
    Consum Rep; 2005 Feb; 70(2):36-8. PubMed ID: 15709291
    [No Abstract]   [Full Text] [Related]  

  • 2. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
    Schreiber CA; Creinin MD; Reeves MF; Harwood BJ
    Contraception; 2006 Dec; 74(6):458-62. PubMed ID: 17157102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraception after medical abortion.
    Mittal S
    Contraception; 2006 Jul; 74(1):56-60. PubMed ID: 16781262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraception: an investment in lives, health and development.
    Darroch JE; Singh S; Nadeau J
    Issues Brief (Alan Guttmacher Inst); 2008 Dec; (5):1-4. PubMed ID: 19537329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication abortion.
    Bartz D; Goldberg A
    Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance coverage of abortion, contraception and sterilization.
    Muller CF
    Fam Plann Perspect; 1978; 10(2):71-7. PubMed ID: 639967
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternatives to oral regimens of contraception.
    Simon M; Shulman LP
    Minerva Ginecol; 2007 Jun; 59(3):271-86. PubMed ID: 17576404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
    Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
    Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the Clinic. Contraception.
    Woodhams EJ; Gilliam M
    Ann Intern Med; 2012 Oct; 157(7):ITC4-1-ITC4-15; quiz ITC4-16. PubMed ID: 23027331
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
    Li L; Zhou Z; Huang L
    Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
    Li CL; Wei M; Fu MF; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting women's contraceptive needs in the Philippines.
    Darroch JE; Singh S; Bal H; Cabigon JV
    Issues Brief (Alan Guttmacher Inst); 2009; (1):1-8. PubMed ID: 19537330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone and misoprostol sequential regimen side effects, complications and safety.
    Sitruk-Ware R
    Contraception; 2006 Jul; 74(1):48-55. PubMed ID: 16781261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.